Literature DB >> 18375743

Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium.

Jonathan L Koff1, Matt X G Shao, Iris F Ueki, Jay A Nadel.   

Abstract

Toll-like receptors (TLRs) are critical for the recognition of inhaled pathogens that deposit on the airway epithelial surface. The epithelial response to pathogens includes signaling cascades that activate the EGF receptor (EGFR). We hypothesized that TLRs communicate with EGFR via epithelial signaling to produce certain innate immune responses. Airway epithelium expresses the highest levels of TLR2, TLR3, TLR5, and TLR6, and here we found that ligands for these TLRs increased IL-8 and VEGF production in normal human bronchial epithelial cells. These effects were prevented by treatment with a selective inhibitor of EGFR phosphorylation (AG-1478), a metalloprotease (MP) inhibitor, a reactive oxygen species (ROS) scavenger, and an NADPH oxidase inhibitor. In an airway epithelial cell line (NCI-H292), TNF-alpha-converting enzyme (TACE) small interfering RNA (siRNA) was used to confirm that TACE is the MP involved in TLR ligand-induced IL-8 and VEGF production. We show that transforming growth factor (TGF)-alpha is the EGFR ligand in this signaling cascade by using TGF-alpha neutralizing antibody and by showing that epithelial production of TGF-alpha occurs in response to TLR ligands. Dual oxidase 1 (Duox1) siRNA was used to confirm that Duox1 is the NADPH oxidase involved in TLR ligand-induced IL-8 and VEGF production. We conclude that multiple TLR ligands induce airway epithelial cell production of IL-8 and VEGF via a Duox1--> ROS--> TACE--> TGF-alpha--> EGFR phosphorylation pathway. These results show for the first time that multiple TLRs in airway epithelial cells produce innate immune responses by activating EGFR via an epithelial cell signaling cascade.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375743     DOI: 10.1152/ajplung.00025.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  100 in total

1.  Toll-like receptor 3 acts as a suppressor gene in breast cancer initiation and progression: a two-stage association study and functional investigation.

Authors:  Lei Fan; Peng Zhou; Qi Hong; Ao-Xiang Chen; Guang-Yu Liu; Ke-Da Yu; Zhi-Ming Shao
Journal:  Oncoimmunology       Date:  2019-03-30       Impact factor: 8.110

2.  Differentiated murine airway epithelial cells synthesize a leukocyte-adhesive hyaluronan matrix in response to endoplasmic reticulum stress.

Authors:  Mark E Lauer; Serpil C Erzurum; Durba Mukhopadhyay; Amit Vasanji; Judith Drazba; Aimin Wang; Csaba Fulop; Vincent C Hascall
Journal:  J Biol Chem       Date:  2008-07-21       Impact factor: 5.157

Review 3.  Structural aspects of airway remodeling in asthma.

Authors:  Sana Siddiqui; James G Martin
Journal:  Curr Allergy Asthma Rep       Date:  2008-11       Impact factor: 4.806

4.  Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis.

Authors:  Ning Lu; Lihong Wang; Hailong Cao; Liping Liu; Luc Van Kaer; Mary K Washington; Michael J Rosen; Philip E Dubé; Keith T Wilson; Xiubao Ren; Xishan Hao; D Brent Polk; Fang Yan
Journal:  J Immunol       Date:  2014-01-03       Impact factor: 5.422

Review 5.  Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung.

Authors:  Toru Nyunoya; Yohannes Mebratu; Amelia Contreras; Monica Delgado; Hitendra S Chand; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2014-03       Impact factor: 6.914

6.  MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands.

Authors:  Katharina Brandl; Lei Sun; Christina Neppl; Owen M Siggs; Sylvain M Le Gall; Wataru Tomisato; Xiaohong Li; Xin Du; Daniela N Maennel; Carl P Blobel; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

Review 7.  Dual oxidase: a novel therapeutic target in allergic disease.

Authors:  Albert van der Vliet; Karamatullah Danyal; David E Heppner
Journal:  Br J Pharmacol       Date:  2018-03-15       Impact factor: 8.739

8.  Dual oxidase 2 in lung epithelia is essential for hyperoxia-induced acute lung injury in mice.

Authors:  Min-Ji Kim; Jae-Chan Ryu; Younghee Kwon; Suhee Lee; Yun Soo Bae; Joo-Heon Yoon; Ji-Hwan Ryu
Journal:  Antioxid Redox Signal       Date:  2014-06-26       Impact factor: 8.401

9.  HSP90 inhibitor geldanamycin reverts IL-13- and IL-17-induced airway goblet cell metaplasia.

Authors:  Alejandro A Pezzulo; Rosarie A Tudas; Carley G Stewart; Luis G Vargas Buonfiglio; Brian D Lindsay; Peter J Taft; Nicholas D Gansemer; Joseph Zabner
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

10.  Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.

Authors:  Satoshi Okazaki; Sebastian Stintzing; Yu Sunakawa; Shu Cao; Wu Zhang; Dongyun Yang; Yan Ning; Satoshi Matsusaka; Martin D Berger; Yuji Miyamoto; Mitsukuni Suenaga; Marta Schirripa; Jordan D West; Roel Gopez; Tsuji Akihito; Wataru Ichikawa; Volker Heinemann; R William DePaolo; Heinz-Josef Lenz
Journal:  Int J Cancer       Date:  2017-06-21       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.